Evidence map›Paper›PMID 32707536›Full record

ArticleMolecular immunology2020

Characterization of 3(3,4-dihydroxy-phenyl) propionic acid as a novel microbiome-derived epigenetic modifier in attenuation of immune inflammatory response in human monocytes.

Jun Wang, Jennifer Blaze, Fatemeh Haghighi, Seunghee Kim-Schulze, Urdvha Raval, Kyle J Trageser, Giulio Maria Pasinetti

Open access · hybridAbstract read
In one paragraph

Article in Molecular immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jun WangDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States; Research and Development Service, Geriatric Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States.
Jennifer BlazeDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, United States.
Fatemeh HaghighiDepartment of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, United States; Research and Development Service, Geriatric Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States.
Seunghee Kim-SchulzeHuman Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, United States.
Urdvha RavalDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States.
Kyle J TrageserDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States.
Giulio Maria PasinettiDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States; Research and Development Service, Geriatric Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, NY, United States. Electronic address: giulio.pasinetti@mssm.edu.
Icahn School of Medicine at Mount Sinai · USGeriatric Research Education and Clinical Center · US

Funding

Pasinetti: Project 3; Role of Microbiome in Promotion of Cognitive and Psychological Resilience (Faith)P50AT008661 · NCCIH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FAITH, JEREMIAH JAMES · 2015 to 2019
$11.2M
Neuroinflammatory and Epigenetic Mechanisms of Blood-Brain Barrier Compromise in SuicideI01BX003794 · VA · JAMES J PETERS VA MEDICAL CENTER · PI HAGHIGHI, FATEMEH G · 2018 to 2024
–
DNA Methylation and Inflammatory Signatures Associated with Suicide Risk and Treatment in US VeteransI01CX001395 · VA · JAMES J PETERS VA MEDICAL CENTER · PI HAGHIGHI, FATEMEH G · 2017 to 2023
–
Identifying Bio-signatures of Suicidal Subtypes in VeteransI01CX001728 · VA · JAMES J PETERS VA MEDICAL CENTER · PI HAGHIGHI, FATEMEH G · 2019 to 2023
–
Novel Prophylactic and Therapeutic Interventions for Stress-Induced DepressionI01BX003005 · VA · JAMES J PETERS VA MEDICAL CENTER · PI PASINETTI, GIULIO MARIA · 2017 to 2022
–
BLR&D Research Career Scientist Award ApplicationIK6BX003785 · VA · JAMES J PETERS VA MEDICAL CENTER · PI PASINETTI, GIULIO MARIA · 2017 to 2025
–
CSR&D Research Career Scientist Award ApplicationIK6CX002074 · VA · JAMES J PETERS VA MEDICAL CENTER · PI HAGHIGHI, FATEMEH G · 2020 to 2025
–
Epigenetic Mechanisms in Blast Related Traumatic Brain InjuryI01RX001705 · VA · JAMES J PETERS VA MEDICAL CENTER · PI HAGHIGHI, FATEMEH G · 2016 to 2022
–
BLRD VA I01 BX003005BLRD VA I01 BX003794BLRD VA IK6 BX003785CSRD VA I01 CX001395CSRD VA I01 CX001728CSRD VA IK6 CX002074NCCIH NIH HHS P50 AT008661RRD VA I01 RX001705
6 · The paper itself

Abstract

Recent studies suggest that microbiome derived 3(3,4-dihydroxy-phenyl) propionic acid (DHCA) attenuates IL-6 cytokine production through downregulation of the epigenetic modifier DNA Methyltransferase 1 (DNMT1) expression and inhibition of DNA methylation at the 5'-C-phosphate-G-3' (CpG)-rich IL6 sequence introns 1 and 3 in a mouse model of depression. In this study, we extended the investigation of DHCA epigenetic mechanisms in IL-6 expression in human peripheral blood mononuclear cells (PBMC). Using Lucia Luciferase reporter gene system we identified CpG-rich sequences in which of methylation is influenced by DHCA similar to what observed in response to treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine. Correlation study showed that DNA methylation at select CpG motifs in the IL-6 promoter correlates with IL-6 gene expression. Our study suggests that DHCA is effective in reducing IL-6 expression in human PBMCs, in part, by regulation of methylation in the IL-6 promoter region.

Indexed as

Cells, CulturedDNA MethylationDown-RegulationGene Expression RegulationHumansInterleukin-6MicrobiotaMonocytesNeuroimmunomodulationPropionatesIL6 protein, humanInterleukin-6Propionates3(3,4-dihydroxy-phenyl) propionic acid (DHCA)EpigeneticsIL-6InflammationPBMCPolyphenols

Identifiers

PMID32707536
PMCPMC7423748
OpenAlexW3045472478

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.